NATURE’S SUNSHINE PRODUCTS, INC. Operating Cash Flow
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Operating Cash Flow of -$1.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $835.00K, a 80.76% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.85M, a 170.76% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $9.90M, a 18.76% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $18.47M, a 92.06% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for fiscal 2025 was $35.32M, a 39.62% increase from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for fiscal 2024 was $25.30M, a 38.64% decline from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for fiscal 2023 was $41.23M, a 5706.48% increase from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $710.00K, a 97.95% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.01M 10-Q · filed 2026-08-06 | $8.89M derived: sum of 3 quarters · filed 2026-08-06 | $27.36M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$1.85M 10-Q · filed 2026-05-07 | $8.05M derived: sum of 2 quarters · filed 2026-05-07 | $26.53M derived: sum of 3 quarters · filed 2026-05-07 | $30.87M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $28.37M derived: sum of 2 quarters · filed 2026-03-10 | $32.71M derived: sum of 3 quarters · filed 2026-08-06 | $35.32M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $18.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $22.81M derived: sum of 2 quarters · filed 2026-08-06 | $25.42M 10-Q · filed 2025-11-06 | $37.61M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.95M 10-Q · filed 2026-08-06 | $19.13M derived: sum of 3 quarters · filed 2026-08-06 | $28.75M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $2.61M 10-Q · filed 2026-05-07 | $14.79M derived: sum of 2 quarters · filed 2026-05-07 | $24.41M derived: sum of 3 quarters · filed 2026-05-07 | $25.72M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $12.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $21.80M derived: sum of 2 quarters · filed 2026-03-10 | $23.11M derived: sum of 3 quarters · filed 2026-03-10 | $25.30M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $9.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.92M derived: sum of 2 quarters · filed 2025-11-06 | $13.11M 10-Q · filed 2025-11-06 | $22.71M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $3.50M 10-Q · filed 2025-07-31 | $13.09M derived: sum of 3 quarters · filed 2025-07-31 | $27.46M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $2.19M 10-Q · filed 2025-05-06 | $11.79M derived: sum of 2 quarters · filed 2025-05-06 | $26.15M derived: sum of 3 quarters · filed 2025-05-06 | $34.09M derived: sum of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $23.96M derived: sum of 2 quarters · filed 2025-03-11 | $31.90M derived: sum of 3 quarters · filed 2025-03-11 | $41.23M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $14.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $22.30M derived: sum of 2 quarters · filed 2024-11-07 | $31.63M 10-Q · filed 2024-11-07 | $35.20M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $7.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $17.26M 10-Q · filed 2024-08-08 | $20.84M derived: sum of 3 quarters · filed 2024-08-08 | $27.32M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $9.32M 10-Q · filed 2024-05-07 | $12.90M derived: sum of 2 quarters · filed 2024-05-07 | $19.38M derived: sum of 3 quarters · filed 2024-05-07 | $17.96M derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $10.05M derived: sum of 2 quarters · filed 2024-03-12 | $8.63M derived: sum of 3 quarters · filed 2024-03-12 | $710.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $6.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $5.06M derived: sum of 2 quarters · filed 2023-11-07 | -$2.87M 10-Q · filed 2023-11-07 | $11.46M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$9.34M 10-Q · filed 2023-08-09 | $4.98M derived: sum of 3 quarters · filed 2023-08-09 | $14.55M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$7.92M 10-Q · filed 2023-05-09 | $6.40M derived: sum of 2 quarters · filed 2023-05-09 | $15.97M derived: sum of 3 quarters · filed 2023-05-09 | $23.95M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $14.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $23.90M derived: sum of 2 quarters · filed 2023-03-16 | $31.87M derived: sum of 3 quarters · filed 2023-03-16 | $34.61M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $9.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $17.55M derived: sum of 2 quarters · filed 2022-11-03 | $20.28M 10-Q · filed 2022-11-03 | $31.09M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $7.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $10.71M 10-Q · filed 2022-08-09 | $21.52M derived: sum of 3 quarters · filed 2022-08-09 | $33.95M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $2.73M 10-Q · filed 2022-05-05 | $13.54M derived: sum of 2 quarters · filed 2022-05-05 | $25.97M derived: sum of 3 quarters · filed 2022-05-05 | $26.88M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $10.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $23.24M derived: sum of 2 quarters · filed 2022-03-08 | $24.14M derived: sum of 3 quarters · filed 2022-03-08 | $37.66M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $12.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $13.33M derived: sum of 2 quarters · filed 2021-11-04 | $26.85M 10-Q · filed 2021-11-04 | $29.88M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $904.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $14.42M 10-Q · filed 2021-08-05 | $17.45M derived: sum of 3 quarters · filed 2021-08-05 | $24.11M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $13.52M 10-Q · filed 2021-05-06 | $16.55M derived: sum of 2 quarters · filed 2021-05-06 | $23.20M derived: sum of 3 quarters · filed 2021-05-06 | $25.96M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $9.69M derived: sum of 2 quarters · filed 2021-03-10 | $12.44M derived: sum of 3 quarters · filed 2021-03-10 | $8.54M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $6.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $9.41M derived: sum of 2 quarters · filed 2020-11-09 | $5.51M 10-Q · filed 2020-11-09 | $13.14M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.14M 10-Q · filed 2020-08-06 | $6.48M derived: sum of 3 quarters · filed 2020-08-06 | $11.25M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | -$3.90M 10-Q · filed 2020-05-11 | -$4.61M 10-Q · filed 2019-05-09 | $3.73M derived: sum of 2 quarters · filed 2020-05-11 | $8.50M derived: sum of 3 quarters · filed 2020-05-11 | $14.22M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $12.40M derived: sum of 2 quarters · filed 2020-03-11 | $18.12M derived: sum of 3 quarters · filed 2020-03-11 | $21.83M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $4.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $10.49M derived: sum of 2 quarters · filed 2019-11-07 | $14.21M 10-Q · filed 2019-11-07 | $16.69M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $5.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $9.44M 10-Q · filed 2019-08-09 | $11.93M derived: sum of 3 quarters · filed 2019-08-09 | $20.64M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $3.71M 10-Q · filed 2019-05-09 | $6.20M derived: sum of 2 quarters · filed 2019-05-09 | $14.92M derived: sum of 3 quarters · filed 2019-05-09 | $13.46M derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $11.21M derived: sum of 2 quarters · filed 2019-03-08 | $9.75M derived: sum of 3 quarters · filed 2019-03-08 | $10.52M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $8.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $7.26M derived: sum of 2 quarters · filed 2018-11-08 | $8.04M 10-Q · filed 2018-11-08 | $6.39M derived: sum of 4 quarters · filed 2019-03-08 | |
| 2017-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$684.00K 10-Q · filed 2018-08-08 | -$2.33M derived: sum of 3 quarters · filed 2019-03-08 | -$3.73M derived: sum of 4 quarters · filed 2019-03-08 | |
| 2017-03-31 | $774.00K 10-Q · filed 2018-05-10 | -$871.00K derived: sum of 2 quarters · filed 2019-03-08 | -$2.27M derived: sum of 3 quarters · filed 2019-03-08 | $1.33M derived: sum of 4 quarters · filed 2019-03-08 | |
| 2016-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$3.05M derived: sum of 2 quarters · filed 2019-03-08 | $555.00K derived: sum of 3 quarters · filed 2019-03-08 | $3.42M 10-K · filed 2019-03-08 | |
| 2016-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.20M derived: sum of 2 quarters · filed 2017-11-09 | $5.06M 10-Q · filed 2017-11-09 | $7.05M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $6.46M 10-Q · filed 2017-08-09 | $8.45M derived: sum of 3 quarters · filed 2018-03-16 | $13.50M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $2.86M 10-Q · filed 2017-05-10 | $4.85M derived: sum of 2 quarters · filed 2018-03-16 | $9.89M derived: sum of 3 quarters · filed 2018-03-16 | $13.95M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $7.03M derived: sum of 2 quarters · filed 2018-03-16 | $11.09M derived: sum of 3 quarters · filed 2018-03-16 | $10.16M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $9.10M derived: sum of 2 quarters · filed 2016-11-09 | $8.18M 10-Q · filed 2016-11-09 | $8.82M derived: sum of 4 quarters · filed 2017-03-14 | |
| 2015-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.13M 10-Q · filed 2016-08-09 | $3.77M derived: sum of 3 quarters · filed 2017-03-14 | $9.17M derived: sum of 4 quarters · filed 2017-03-14 | |
| 2015-03-31 | -$926.00K 10-Q · filed 2016-05-10 | -$285.00K derived: sum of 2 quarters · filed 2017-03-14 | $5.12M derived: sum of 3 quarters · filed 2017-03-14 | $12.77M derived: sum of 4 quarters · filed 2017-03-14 | |
| 2014-12-31 | $641.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $6.04M derived: sum of 2 quarters · filed 2017-03-14 | $13.69M derived: sum of 3 quarters · filed 2017-03-14 | $14.18M 10-K · filed 2017-03-14 | |
| 2014-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $13.05M derived: sum of 2 quarters · filed 2015-11-06 | $13.54M 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $7.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $8.14M 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $490.00K 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | $29.38M 10-K · filed 2016-03-14 | ||||
| 2012-12-31 | $26.65M 10-K · filed 2015-03-13 | ||||
| 2011-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$11.93M derived: sum of 2 quarters · filed 2013-03-07 | $3.91M 10-K · filed 2013-03-07 | ||
| 2011-09-30 | -$19.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$4.12M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $15.84M 10-Q · filed 2011-08-05 | ||||
| 2010-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $10.77M derived: sum of 2 quarters · filed 2013-03-07 | $16.15M 10-K · filed 2013-03-07 | ||
| 2010-09-30 | $4.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $10.22M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $5.38M 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $927.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |